Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Fletcher R John, Director. Director active across 6 companies, notably Vyant Bio, Inc.. Cumulatively, 56 reports have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €129k. History available since 17 May 2021. The latest transaction was disclosed on 1 July 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Fletcher R John
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8,226 shares@ US$2.747.8% of flowCommon StockSEC:0001161697-23-000516:0
25 of 56 declarations
About Fletcher R John
FLETCHER R JOHN is a Director and has 56 filings in total. In the 56 most recent filings in our sample, buy amounts are EUR 129284, sell amounts are EUR 0, and the covered period runs from 2021-05-18 to 2026-07-06. He is a director of ClearPoint Neuro, Inc., KORU Medical Systems, Inc., Vyant Bio, Inc. and Repro MED Systems INC, and the modal transaction nature is Attribution.